Friday, February 23, 2024 |

Baltimore biotech backed by more than $300M in funding names new CEO

January 8, 2024

One of Baltimore’s largest biotechnology companies has hired a new CEO as it pushes toward a wider commercial launch of its early cancer detection device. Delfi Diagnostics announced on Friday that Susan Tousi will take over as CEO, replacing founder Victor Velculescu. Velculescu will remain a member of the company’s board of directors.

Article Source: Baltimore Business Journal

The Morning Rundown

We’re staying up to the minute on the issues shaping the future. Join us on the newsletter of choice for Maryland politicos and business leaders. It’s always free to join and never a hassle to leave. See you on the inside.